RxDoctor Payments Data

Susan Lurie, MD

Family Medicine · Miami Beach, FLNPI 1104930353

Payments from drug & device makers

$3,706in general payments, 2019–2025

Across 204 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$464
  • AbbVie$427
  • Lilly USA, LLC$416
  • Pfizer$378
  • Insulet Corporation$264
  • Tandem Diabetes Care, Inc.$177
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$3,691100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,706 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$79,400
Medicare patients
227
Services billed
803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$49,092
OzempicSemaglutide39$42,125
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$27,172
XareltoRivaroxaban14$23,159
LinzessLinaclotide14$21,308
MounjaroTirzepatide18$21,144
MyrbetriqMirabegron20$13,472
Breo ElliptaFluticasone/Vilanterol11$5,413
SynthroidLevothyroxine Sodium37$2,668
Rosuvastatin Calcium186$2,361
Atorvastatin Calcium184$1,818
Mirtazapine56$1,740
Losartan Potassium122$1,577
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,270
Levothyroxine Sodium106$1,190

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$378$49,09249 claims
Novo NordiskOzempic$464$42,12539 claims
GSKTrelegy Ellipta, Breo Ellipta$162$32,58540 claims
AbbVieLinzess, Synthroid$427$23,97651 claims
Johnson & JohnsonXarelto$18$23,15914 claims
Lilly USA, LLCMounjaro$416$21,14418 claims
Astellas Pharma US IncMyrbetriq$39$13,47220 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$43$1,190106 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Miami Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →